Acute normovolaemic haemodilution (ANH) is safe in patients with known coronary artery disease

Introduction

The reduction of autologous blood transfusion is a national priority. The use of ANH as a blood conservation strategy remains controversial and under-investigated [1]. A recent paper [2] concluded that ANH should be avoided in patients with critical coronary stenosis or moderate-to-poor left ventricular function. There are no randomized controlled studies of the safety of ANH.

Objectives

To investigate the safety of ANH using continuous Holter electrocardiography monitoring, serial analysis of daily postoperative electrocardiography, and by the use of troponin I levels.

Methods

Patients presenting for elective coronary artery bypass surgery were randomized into a control or an ANH group. All patients had a four-lead Holter electrocardiography monitor attached 1 h before surgery. After a standard anaesthetic induction, patients in the ANH group had 10 ml/kg blood removed while being maintained within 20% of their baseline blood pressure. This blood was rein-fused after cardiopulmonary bypass. Troponin I levels were taken preoperatively, prebypass and at 24 h. All patients had daily postoperative electrocardiography analysis.

Results

The results are shown in Table 1.

Table 1

Conclusion

ANH is safe. There is no evidence of an additional ischaemic burden after haemodilution.